설명
Baseline characteristics of pregnant women enrolled in the randomized, double-blind, placebo-controlled trial of fructooligosaccharide (FOS) supplementation are presented.
Figure 1
Source Paper
Maternal Prebiotic Ingestion Increased the Number of Fecal Bifidobacteria in Pregnant Women but Not in Their Neonates Aged One Month.Cite This Figure
![Figure 1: Baseline characteristics of pregnant women enrolled in the randomized, double-blind, placebo-controlled trial of fructooligosaccharide (FOS) supplementation are presented.]() > Source: Shinji Jinno et al. "Maternal Prebiotic Ingestion Increased the Number of Fecal Bifidobacteria in Pre." *Nutrients*, 2017. PMID: [28245628](https://pubmed.ncbi.nlm.nih.gov/28245628/)
<figure> <img src="" alt="Baseline characteristics of pregnant women enrolled in the randomized, double-blind, placebo-controlled trial of fructooligosaccharide (FOS) supplementation are presented." /> <figcaption>Figure 1. Baseline characteristics of pregnant women enrolled in the randomized, double-blind, placebo-controlled trial of fructooligosaccharide (FOS) supplementation are presented.<br> Source: Shinji Jinno et al. "Maternal Prebiotic Ingestion Increased the Number of Fecal Bifidobacteria in Pre." <em>Nutrients</em>, 2017. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/28245628/">28245628</a></figcaption> </figure>